Abstract
The fruit of Antidesma bunius has both medicinal and edible properties. In previous studies, the fruit extract of A. bunius showed anti-proliferation activity on breast cancer cells, but its functional components and anti-tumor mechanism are still unclear. In this research, the main active components of A. bunius fruits (detected by UHPLC-MS/MS) and the corresponding targets were analyzed by network pharmacology method, and its interactions were verified by molecular docking to explore the possible tumor suppressor mechanisms. A total of 24 active chemical components were screened from fruits extract of A. bunius,and 44 targets genes were intersected with breast cancer, among them, AKT1, ESR1, EGFR, EP300, ERBB2 and AR were the top core targets.The GO enrichment of target genes mainly involved processes of cellular lipid metabolism, response to hormones, tube development, and KEGG pathway analysis centers in cancer pathways present in breast, pancreatic and non-small cell lung cancer.The flavonoids in the fruits of A. bunius showed strong binding to the core targets by molecular docking analysis. These results strongly suggest that the flavonoids in the fruit of A. bunius can inhibit proliferation of breast cancer through multiple targets, mainly by ERK and PI3K-AKT pathways.
References
Abula, G., Ding, W., Li, D., Yan, X., Pei, X., & Xu, H. (2019). Mechanism of Astragalus membranaceus Multi-component synergistic therapy for breast cancer based on network pharmacology. Chemical and Biological Engineering, 10, 35–40.
Butkhup, L., & Samappito, S. (2008). An analysis on flavonoids contents in Mao Luang fruits of fifteen cultivars (Antidesma bunius), grown in northeast Thailand. Pakistan Journal of Biological Sciences: PJBS, 11(7), 996–1002.
Cai, Y., Zeng, M., & Chen, Y.-Z. (2021). The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking. Annals of Palliative Medicine, 10(4), 3864–3895.
Cao, Q., Qin, L., Huang, F., Wang, X., Yang, L., Shi, H., Wu, H., Zhang, B., Chen, Z., & Wu, X. (2017). Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways. Toxicology and Applied Pharmacology, 319, 80–90.
Dai, X. (2016). May Tea of Ming Dynasty in Jiaoyuan Village. Land Greening, 8, 43.
Hickey, T. E., Dwyer, A. R., & Tilley, W. D. (2021). Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer. British Journal of Cancer.
Islam, S., Ahammed, S., Sukorno, F. I., Koly, S. F., Biswas, M., & Hossain, S. (2018). A review on phytochemical and pharmacological potentials of Antidesma bunius. Journal of Analytical & Pharmaceutical Research, Volume 7(Issue 5), 602–604.
Jiang, M., Hu, Y., Lin, G., Chen, C., & Li, H. (2020). Network Pharmacology and Bioinformatics-based Study on Mechanism of Resveratrol Against Triple Negative Breast Cancer. Chinese Journal of Modern Applied Pharmacology, 37(20), 2459–2464.
Krongyut, O., & Sutthanut, K. (2019). Phenolic Profile, Antioxidant Activity, and Anti-obesogenic Bioactivity of Mao Luang Fruits (Antidesma bunius L.). Molecules (Basel, Switzerland), 24(22), E4109.
Li, B., & Hoffmann, P. (2008). ANTIDESMA Burman ex Linnaeus, Sp. Pl. 2: 1027. 1753. Flora of China, 11, 209–215.
Li, H., Zhao, B., Liu, Y., Deng, W., & Zhang, Y. (2020). Angiogenesis in residual cancer and roles of HIF-1α, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer. Folia Morphologica, 79(1), 71–78.
Li, J. (1995). Composition preparation and clinical verification of Burn past. Guangxi Traditional Chinese Medicine, 6, 35.
Ma, F., Huang, D., Song, S., Wu, B., Guo, G., Wang, D., & Tan, L. (2020). Inhibitory Activity of Extracts of Antidesma montanum on the Proliferation of Breast Cancer Cells MDA-MB-231. Chinese journal of tropical crops, 41(8), 1693–1699.
Ma, F., Masood, T., Huang, D., Wu, B., Ge, Y., Chen, D., Gutierrez-Pajares, J. L., Nasiruddin, & Song, S. (2021). Inhibitory Activity of Fruits Extracts of Antidesma bunius on the Proliferation and Migration of MDA-MB-231 Breast Cancer Cells. Journal of Food and Nutrition Research, 9(2), 61–67.
Micor, J. R., Deocaris, C. C., & Mojica, E.-R. E. (2005). Biological Activity of Bignay [Antidesma bunius (L.) Spreng] Crude Extract in Artemia salina. Journal of Medical Sciences, 5(3), 195–198.
Park, J.-Y., Kang, S.-E., Ahn, K. S., Um, J.-Y., Yang, W. M., Yun, M., & Lee, S.-G. (2020). Inhibition of the PI3K-AKT-mTOR pathway suppresses the adipocyte-mediated proliferation and migration of breast cancer cells. Journal of Cancer, 11(9), 2552–2559.
Pei, J.-S., Liu, C.-C., Hsu, Y.-N., Lin, L.-L., Wang, S.-C., Chung, J.-G., Bau, D.-T., & Lin, S.-S. (2012). Amentoflavone induces cell-cycle arrest and apoptosis in MCF-7 human breast cancer cells via mitochondria-dependent pathway. In Vivo (Athens, Greece), 26(6), 963–970.
Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., Xu, X., Li, Y., Wang, Y., & Yang, L. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6, 13.
Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020). Roles of flavonoids against coronavirus infection. Chemico-Biological Interactions, 328, 109211.
Shanghai Science and Technology Press. (1999). May Tea【Chinese Medicinal Materials Collection】Chinese Medicine Collection.
Wei, Gao. (2015). Study on the chemical constituents of Dendrobium gratiosissmum and Antidesma bunius [硕士, Anhui University of Traditional Chinese Medicine].
Zhaohui, A. (2011). Preliminary study on chemical components of Antidesma montanum. China Medical Herald, 8(13), 37–38.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Funing MA, Jorge Luis Gutierrez-Pajares, Dongmei HUANG, Yi XU, Bin WU, Shun SONG